Global Actigraphy Device Market Size Study, By Application (Sleep Disorders, Physical Activity Monitoring, Chronic Disease Management), By End-Use (Healthcare Providers, Research Institutions, Homecare Settings, Fitness and Sports Centers), and Regional F
Description
The Global Actigraphy Device Market was valued at approximately USD 2.64 billion in 2024 and is anticipated to grow with a CAGR of 27.4% over the forecast period 2025-2034. The increasing prevalence of sleep disorders such as insomnia, sleep apnea, and restless legs syndrome is a primary factor driving market growth. As individuals worldwide become more aware of the critical role sleep plays in overall health and well-being, there has been a surge in demand for non-invasive sleep monitoring solutions.
Actigraphy devices are gaining widespread adoption among healthcare providers, research institutions, and homecare settings due to their ability to provide continuous, real-time insights into sleep patterns and activity levels. Unlike polysomnography (PSG), which requires in-clinic monitoring, actigraphy devices offer cost-effective, long-term monitoring that enhances diagnostic accuracy and improves patient outcomes. Moreover, advancements in sensor technology, AI-driven sleep analytics, and wearable device integration have further positioned actigraphy devices as a key tool in sleep disorder management.
The aging global population has also significantly contributed to market growth. Elderly individuals frequently experience sleep fragmentation, insomnia, and other disturbances, making continuous sleep monitoring crucial for their well-being. For instance, the percentage of people aged 65 and older globally is expected to rise to 20.7% by 2074, according to UN projections. The increasing geriatric demographic is likely to drive the demand for home-based sleep tracking solutions, creating lucrative opportunities for actigraphy device manufacturers.
Despite the growing demand, the market faces regulatory challenges as compliance with FDA, EMA, and other global health regulations requires rigorous clinical validation. However, ongoing research efforts and strategic collaborations among industry leaders aim to streamline product approval processes while maintaining device accuracy and reliability. Additionally, increasing insurance coverage for sleep disorder diagnostics is expected to mitigate cost barriers and further fuel market penetration.
Regionally, North America dominated the market in 2024, accounting for over 35.76% of the global revenue share. This dominance is attributed to high healthcare expenditures, advanced sleep research infrastructure, and a strong presence of key market players. Meanwhile, Asia-Pacific is projected to witness the fastest CAGR, driven by rising disposable incomes, expanding healthcare access, and growing awareness about sleep disorders in emerging economies such as China, India, and Japan.
Major Market Players Included in This Report Are:
By Application
North America
Actigraphy devices are gaining widespread adoption among healthcare providers, research institutions, and homecare settings due to their ability to provide continuous, real-time insights into sleep patterns and activity levels. Unlike polysomnography (PSG), which requires in-clinic monitoring, actigraphy devices offer cost-effective, long-term monitoring that enhances diagnostic accuracy and improves patient outcomes. Moreover, advancements in sensor technology, AI-driven sleep analytics, and wearable device integration have further positioned actigraphy devices as a key tool in sleep disorder management.
The aging global population has also significantly contributed to market growth. Elderly individuals frequently experience sleep fragmentation, insomnia, and other disturbances, making continuous sleep monitoring crucial for their well-being. For instance, the percentage of people aged 65 and older globally is expected to rise to 20.7% by 2074, according to UN projections. The increasing geriatric demographic is likely to drive the demand for home-based sleep tracking solutions, creating lucrative opportunities for actigraphy device manufacturers.
Despite the growing demand, the market faces regulatory challenges as compliance with FDA, EMA, and other global health regulations requires rigorous clinical validation. However, ongoing research efforts and strategic collaborations among industry leaders aim to streamline product approval processes while maintaining device accuracy and reliability. Additionally, increasing insurance coverage for sleep disorder diagnostics is expected to mitigate cost barriers and further fuel market penetration.
Regionally, North America dominated the market in 2024, accounting for over 35.76% of the global revenue share. This dominance is attributed to high healthcare expenditures, advanced sleep research infrastructure, and a strong presence of key market players. Meanwhile, Asia-Pacific is projected to witness the fastest CAGR, driven by rising disposable incomes, expanding healthcare access, and growing awareness about sleep disorders in emerging economies such as China, India, and Japan.
Major Market Players Included in This Report Are:
- ActiGraph, LLC
- Fibion Inc.
- Koninklijke Philips N.V.
- CamNtech Ltd.
- Empatica Inc.
- ActivInsights Ltd.
- Neurocare Group AG
- Withings SA
- Garmin Ltd.
- Fitbit Inc. (Google)
- Nox Medical
- VitalConnect
- Polar Electro Oy
- Somfit
- BioSerenity
By Application
- Sleep Disorders
- Physical Activity Monitoring
- Chronic Disease Management
- Healthcare Providers
- Research Institutions
- Homecare Settings
- Fitness and Sports Centers
North America
- U.S.
- Canada
- Mexico
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Japan
- China
- India
- Thailand
- South Korea
- Australia
- Brazil
- Argentina
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Historical Year – 2022
- Base Year – 2024
- Forecast Period – 2024 to 2034
- Market Estimates & Forecast for 10 years from 2022 to 2034
- Annualized revenues and regional level analysis for each market segment
- Detailed analysis of geographical landscape with Country-level analysis of major regions
- Competitive landscape with information on major players in the market
- Analysis of key business strategies and recommendations on future market approach
- Analysis of competitive structure of the market
- Demand-side and supply-side analysis of the market
Table of Contents
285 Pages
- Chapter 1. Global Actigraphy Device Market Executive Summary
- 1.1. Global Actigraphy Device Market Size & Forecast (2024-2034)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Application
- 1.3.2. By End-Use
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6 Industry Metrics
- 1.7 Investment Analysis
- 1.8 Investment Rationale
- 1.9. Analyst Recommendation & ConclusionChapter 2. Global Actigraphy Device Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Actigraphy Device Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Increasing prevalence of sleep disorders and growing awareness of sleep health
- 3.1.2. Growing adoption of wearable health tracking devices and telemedicine integration
- 3.1.3. Rising geriatric population and their susceptibility to sleep disturbances
- 3.2. Market Challenges
- 3.2.1. Regulatory constraints and approval complexities for medical devices
- 3.2.2. Data privacy concerns and cybersecurity threats in remote monitoring devices
- 3.3. Market Opportunities
- 3.3.1. Integration of AI-powered analytics for improved sleep tracking and diagnostics
- 3.3.2. Expanding home-based healthcare and personalized health solutions
- Chapter 4. Global Actigraphy Device Market Industry Analysis
- 4.1. Porter’s Five Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s Five Force Model
- 4.1.7. Porter’s Five Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunities
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Actigraphy Device Market Size & Forecasts by Application (2024-2034)
- 5.1. Segment Dashboard
- 5.2. Global Actigraphy Device Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Sleep Disorders
- 5.2.2. Physical Activity Monitoring
- 5.2.3. Chronic Disease Management
- Chapter 6. Global Actigraphy Device Market Size & Forecasts by End-Use (2024-2034)
- 6.1. Segment Dashboard
- 6.2. Global Actigraphy Device Market: End-Use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Healthcare Providers
- 6.2.2. Research Institutions
- 6.2.3. Homecare Settings
- 6.2.4. Fitness and Sports Centers
- Chapter 7. Global Actigraphy Device Market Size & Forecasts by Region (2024-2034)
- 7.1. North America Actigraphy Device Market
- 7.1.1. U.S. Actigraphy Device Market
- 7.1.1.1. Application Breakdown Size & Forecasts, 2022-2032
- 7.1.1.2. End-Use Breakdown Size & Forecasts, 2022-2032
- 7.1.2. Canada Actigraphy Device Market
- 7.1.3. Mexico Actigraphy Device Market
- 7.2. Europe Actigraphy Device Market
- 7.2.1. U.K. Actigraphy Device Market
- 7.2.2. Germany Actigraphy Device Market
- 7.2.3. France Actigraphy Device Market
- 7.2.4. Italy Actigraphy Device Market
- 7.2.5. Spain Actigraphy Device Market
- 7.2.6. Denmark Actigraphy Device Market
- 7.2.7. Sweden Actigraphy Device Market
- 7.2.8. Norway Actigraphy Device Market
- 7.2.9. Rest of Europe Actigraphy Device Market
- 7.3. Asia-Pacific Actigraphy Device Market
- 7.3.1. Japan Actigraphy Device Market
- 7.3.2. China Actigraphy Device Market
- 7.3.3. India Actigraphy Device Market
- 7.3.4. Thailand Actigraphy Device Market
- 7.3.5. South Korea Actigraphy Device Market
- 7.3.6. Australia Actigraphy Device Market
- 7.3.7. Rest of Asia Pacific Actigraphy Device Market
- 7.4. Latin America Actigraphy Device Market
- 7.4.1. Brazil Actigraphy Device Market
- 7.4.2. Argentina Actigraphy Device Market
- 7.4.3. Rest of Latin America Actigraphy Device Market
- 7.5. Middle East & Africa Actigraphy Device Market
- 7.5.1. South Africa Actigraphy Device Market
- 7.5.2. Saudi Arabia Actigraphy Device Market
- 7.5.3. UAE Actigraphy Device Market
- 7.5.4. Kuwait Actigraphy Device Market
- 7.5.5. Rest of Middle East & Africa Actigraphy Device Market
- Chapter 8. Competitive Intelligence
- 8.1. Key Company SWOT Analysis
- 8.1.1. ActiGraph, LLC
- 8.1.2. Fibion Inc.
- 8.1.3. Koninklijke Philips N.V.
- 8.2. Top Market Strategies
- 8.3. Company Profiles
- 8.3.1. ActiGraph, LLC
- 8.3.2. Fibion Inc.
- 8.3.3. Koninklijke Philips N.V.
- 8.3.4. CamNtech Ltd
- 8.3.5. Empatica Inc.
- 8.3.6. ActivInsights Ltd
- 8.3.7. Neurocare Group AG
- 8.3.8. Withings SA
- 8.3.9. Garmin Ltd.
- 8.3.10. Fitbit Inc. (Google)
- Chapter 9. Research Process
- 9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
- 9.2. Research Attributes
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
